Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Role of Leaders in Fostering Meaningful Collaborations Between Academic Medical Centers and Industry While Also Managing Individual and Institutional Conflicts of Interest.

Pizzo PA, Lawley TJ, Rubenstein AH.

JAMA. 2017 May 2;317(17):1729-1730. doi: 10.1001/jama.2017.2573. No abstract available.

PMID:
28464157
2.

Medical education: time for reform.

Lawley TJ, Saxton JF, Johns MM.

Trans Am Clin Climatol Assoc. 2005;116:311-7; discussion 317-20. No abstract available.

3.

"It was the best of times; it was the worst of times".

Lawley TJ, Zaidan JR.

J Med Assoc Ga. 2004;93(3):50-3. No abstract available.

PMID:
15790043
4.

Conflict of interest and the public trust: a dean's view.

Lawley TJ, Adkison CR.

Trans Am Clin Climatol Assoc. 2003;114:369-82; discussion 382-4. No abstract available.

5.

Hypersensitivity vasculitis--not always benign?

Swerlick RA, Lawley TJ.

Lancet. 1997 Aug 2;350(9074):306-7. No abstract available.

PMID:
9251631
6.
7.

Human microvascular endothelial cells adhere to thrombospondin-1 via an RGD/CSVTCG domain independent mechanism.

Chen ZS, Pohl J, Lawley TJ, Swerlick RA.

J Invest Dermatol. 1996 Feb;106(2):215-20.

9.

Polarized expression and basic fibroblast growth factor-induced down-regulation of the alpha 6 beta 4 integrin complex on human microvascular endothelial cells.

Sepp NT, Cornelius LA, Romani N, Li LJ, Caughman SW, Lawley TJ, Swerlick RA.

J Invest Dermatol. 1995 Feb;104(2):266-70.

10.

Nodular scleroderma.

Krell JM, Solomon AR, Glavey CM, Lawley TJ.

J Am Acad Dermatol. 1995 Feb;32(2 Pt 2):343-5. Review.

PMID:
7829737
11.

The role of adhesion molecules in cutaneous inflammation.

Lawley TJ, Caughman SW, Swerlick RA, Xu Y.

J Dermatol. 1994 Nov;21(11):790-4. Review. No abstract available.

PMID:
7852639
12.

Basic fibroblast growth factor increases expression of the alpha v beta 3 integrin complex on human microvascular endothelial cells.

Sepp NT, Li LJ, Lee KH, Brown EJ, Caughman SW, Lawley TJ, Swerlick RA.

J Invest Dermatol. 1994 Sep;103(3):295-9.

13.

Selective upregulation of intercellular adhesion molecule (ICAM-1) by ultraviolet B in human dermal microvascular endothelial cells.

Cornelius LA, Sepp N, Li LJ, Degitz K, Swerlick RA, Lawley TJ, Caughman SW.

J Invest Dermatol. 1994 Jul;103(1):23-8.

14.
15.

A factor in human plasma permits persistent expression of E-selectin by human endothelial cells.

Sepp NT, Gille J, Li LJ, Caughman SW, Lawley TJ, Swerlick RA.

J Invest Dermatol. 1994 Apr;102(4):445-50.

16.
17.

A 5' portion of the ICAM-1 gene confers tissue-specific differential expression levels and cytokine responsiveness.

Cornelius LA, Taylor JT, Degitz K, Li LJ, Lawley TJ, Caughman SW.

J Invest Dermatol. 1993 Jun;100(6):753-8.

18.

Role of microvascular endothelial cells in inflammation.

Swerlick RA, Lawley TJ.

J Invest Dermatol. 1993 Jan;100(1):111S-115S. Review.

PMID:
8423379
19.

Use of a human microvascular endothelial cell line as a model system to evaluate cholesterol uptake.

Pruckler JM, Lawley TJ, Ades EW.

Pathobiology. 1993;61(5-6):283-7.

PMID:
8297494
20.

Antigen presentation by a continuous human microvascular endothelial cell line, HMEC-1, to human T cells.

Bosse D, George V, Candal FJ, Lawley TJ, Ades EW.

Pathobiology. 1993;61(3-4):236-8.

PMID:
8216847
21.

HMEC-1: establishment of an immortalized human microvascular endothelial cell line.

Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ.

J Invest Dermatol. 1992 Dec;99(6):683-90.

22.

Expression and modulation of the vitronectin receptor on human dermal microvascular endothelial cells.

Swerlick RA, Brown EJ, Xu Y, Lee KH, Manos S, Lawley TJ.

J Invest Dermatol. 1992 Dec;99(6):715-22.

23.

Regulation of vascular cell adhesion molecule 1 on human dermal microvascular endothelial cells.

Swerlick RA, Lee KH, Li LJ, Sepp NT, Caughman SW, Lawley TJ.

J Immunol. 1992 Jul 15;149(2):698-705.

PMID:
1378077
24.
25.
26.

Cell adhesion molecules and cutaneous inflammation.

Lawley TJ, Kubota Y.

Semin Dermatol. 1991 Sep;10(3):256-9. Review.

PMID:
1931575
27.

Studies of the modulation of MHC antigen and cell adhesion molecule expression on human dermal microvascular endothelial cells.

Swerlick RA, Garcia-Gonzalez E, Kubota Y, Xu YL, Lawley TJ.

J Invest Dermatol. 1991 Aug;97(2):190-6.

28.

Vasculitis.

Lawley TJ, Kubota Y.

Dermatol Clin. 1990 Oct;8(4):681-7. Review.

PMID:
1979020
29.

[Immunophenotypic analysis of human endothelial cells].

Kubota Y, Lawley TJ.

Nihon Hifuka Gakkai Zasshi. 1990 Sep;100(10):1009-16. Japanese.

PMID:
1979995
30.

Cell adhesion molecules.

Garcia-Gonzalez E, Swerlick RA, Lawley TJ.

Am J Dermatopathol. 1990 Apr;12(2):188-92. Review.

PMID:
2184691
31.

Prevalence of thyroid abnormalities in patients with dermatitis herpetiformis and in control subjects with HLA-B8/-DR3.

Gaspari AA, Huang CM, Davey RJ, Bondy C, Lawley TJ, Katz SI.

Am J Med. 1990 Feb;88(2):145-50.

PMID:
2301441
32.
33.

Polymyositis/dermatomyositis associated with dermatitis herpetiformis.

Kalovidouris AE, Miller FW, Lawley TJ.

Arthritis Rheum. 1989 Sep;32(9):1179-81.

PMID:
2789048
34.

Cutaneous vasculitis: its relationship to systemic disease.

Swerlick RA, Lawley TJ.

Med Clin North Am. 1989 Sep;73(5):1221-35.

PMID:
2770379
35.

Inflammatory properties of human C5a and C5a des Arg/ in mast cell-depleted human skin.

Swerlick RA, Yancey KB, Lawley TJ.

J Invest Dermatol. 1989 Sep;93(3):417-22.

36.

Induction of morphologic differentiation of endothelial cells in culture.

Lawley TJ, Kubota Y.

J Invest Dermatol. 1989 Aug;93(2 Suppl):59S-61S.

37.
38.
39.
40.

A direct in vivo comparison of the inflammatory properties of human C5a and C5a des Arg in human skin.

Swerlick RA, Yancey KB, Lawley TJ.

J Immunol. 1988 Apr 1;140(7):2376-81.

PMID:
3351304
41.

Filarial antigen in circulating immune complexes from patients with Wuchereria bancrofti filariasis.

Lunde MN, Paranjape R, Lawley TJ, Ottesen EA.

Am J Trop Med Hyg. 1988 Mar;38(2):366-71.

PMID:
3281495
42.

Human serum sickness: a prospective analysis of 35 patients treated with equine anti-thymocyte globulin for bone marrow failure.

Bielory L, Gascon P, Lawley TJ, Young NS, Frank MM.

Medicine (Baltimore). 1988 Jan;67(1):40-57.

PMID:
3257288
43.

Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies.

Koski CL, Sanders ME, Swoveland PT, Lawley TJ, Shin ML, Frank MM, Joiner KA.

J Clin Invest. 1987 Nov;80(5):1492-7.

44.
45.

Immediate hypersensitivity.

Keahey TM, Yancey KB, Lawley TJ.

J Am Acad Dermatol. 1987 Nov;17(5 Pt 1):826-37. Review. No abstract available.

PMID:
3316320
46.

C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-gamma.

Okusawa S, Dinarello CA, Yancey KB, Endres S, Lawley TJ, Frank MM, Burke JF, Gelfand JA.

J Immunol. 1987 Oct 15;139(8):2635-40.

PMID:
3116090
47.

Patients with bone marrow failure demonstrate decreased cutaneous reactivity to human C5a.

Yancey KB, Bielory L, Wright R, Young N, Frank MM, Lawley TJ.

J Invest Dermatol. 1987 Apr;88(4):388-92.

48.

C5a as a mediator of cutaneous inflammation.

Yancey KB, Swerlick RA, Lawley TJ.

Am J Dermatopathol. 1987 Apr;9(2):138-43. Review.

PMID:
3332749
49.

Characterization of the C3 receptor induced by herpes simplex virus type 1 infection of human epidermal, endothelial, and A431 cells.

Kubota Y, Gaither TA, Cason J, O'Shea JJ, Lawley TJ.

J Immunol. 1987 Feb 15;138(4):1137-42.

PMID:
3027170
50.

Phagocytosis of keratin filament aggregates following opsonization with IgG-anti-keratin filament autoantibodies.

Hintner H, Romani N, Stanzl U, Grubauer G, Fritsch P, Lawley TJ.

J Invest Dermatol. 1987 Feb;88(2):176-82.

Supplemental Content

Loading ...
Support Center